Literature DB >> 29570969

Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis.

Rakesh Jain1,2, Christoph U Correll3,4,5.   

Abstract

Tardive dyskinesia (TD) is an involuntary movement disorder associated with antipsychotic treatment. Because of the serious and potentially irreversible nature of TD, accurate diagnosis is crucial. However, diagnosing TD can be challenging, since the subtle and often fluctuating symptoms can be easily mistaken for symptoms of mental illness or other side effects. Although the risk of developing TD in relation to treatment with second-generation antipsychotics is lower than that associated with first-generation antipsychotics, the risk still exists and may be greater than once believed. Clinicians prescribe antipsychotics for a variety of illnesses and may underestimate the possibility of a patient developing TD, thus missing early signs of the disorder. In this ACADEMIC HIGHLIGHTS, experts review the prevalence, phenomenology, risk factors, and impact of TD, illustrated by case examples, and provide valuable clinical information to guide early recognition and accurate diagnosis. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29570969     DOI: 10.4088/JCP.nu17034ah1c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Valbenazine for the Treatment of Adults with Tardive Dyskinesia.

Authors:  Harshit Gupta; Alycee R Moity; Allison Jumonville; Sarah Kaufman; Amber N Edinoff; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-18

2.  The effects of valbenazine on tardive dyskinesia in older and younger patients.

Authors:  Martha Sajatovic; George S Alexopoulos; Joshua Burke; Khodayar Farahmand; Scott Siegert
Journal:  Int J Geriatr Psychiatry       Date:  2019-10-31       Impact factor: 3.485

3.  Patient perspective of tardive dyskinesia: results from a social media listening study.

Authors:  Mallory Farrar; Leslie Lundt; Ericha Franey; Chuck Yonan
Journal:  BMC Psychiatry       Date:  2021-02-15       Impact factor: 3.630

Review 4.  Tardive Dyskinesia in Older Persons Taking Antipsychotics.

Authors:  Leslie Citrome; Stuart H Isaacson; Danielle Larson; Daniel Kremens
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-14       Impact factor: 2.570

Review 5.  Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations.

Authors:  Richard Jackson; Matthew N Brams; Leslie Citrome; Amber R Hoberg; Stuart H Isaacson; John M Kane; Rajeev Kumar
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-24       Impact factor: 2.570

6.  RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.

Authors:  Stanley N Caroff; Karen Yeomans; William R Lenderking; Andrew J Cutler; Caroline M Tanner; Huda Shalhoub; Véronique Pagé; Jun Chen; Ericha Franey; Chuck Yonan
Journal:  J Clin Psychopharmacol       Date:  2020 May/Jun       Impact factor: 3.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.